Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies
NCT06854276Phase 2Not yet recruiting
- Sponsor
- 3SBio
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- PEGylated Peptides
01
Overview
Phase 2, randomised, open-label trial of SSS06 in Chemotherapy-induced anemia (CIA) (4 arms), sponsored by 3SBio. Primary endpoint: Incidence and severity of adverse events. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
SSS06
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT06854276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854276.